Is Beiersdorf profitable in 2026?

Yes. Beiersdorf reported FY2025 EBIT excluding special factors of €1.4 billion, a 14.0% margin, on group sales of €9.9 billion, as of March 2, 2026. However Q1 2026 organic sales fell -4.6% and NIVEA declined -7.0%, pressuring near-term results.

Is NIVEA in trouble at Beiersdorf?

NIVEA's organic growth slowed to just +0.9% in 2025, then fell -7.0% in Q1 2026 (reported April 21, 2026), prompting a 'NIVEA rebalancing' strategy. Management has said meaningful improvement is expected later in 2026 and into 2027, not immediately.

Who owns Beiersdorf AG?

Beiersdorf is majority controlled by Maxingvest GmbH & Co. KGaA, the Herz family's holding company (formerly Tchibo Holding), which owns 53.50% per Beiersdorf's own investor relations page. Free float is 37.13%, with BlackRock holding roughly 2.96-3.05% as of October 23, 2025.

Could AI replace Beiersdorf's business?

Unlikely for its core products. Beiersdorf holds 140+ years of proprietary clinical skin data, a patented epigenetic 'Skin Age Clock' algorithm (patented since 2021), and 170+ market distribution. AI mainly threatens its consumer diagnostic apps, not its brand or manufacturing moat.

Who is Beiersdorf's biggest competitor?

L'Oréal, whose dermocosmetics brands CeraVe, La Roche-Posay, and Vichy are directly contesting Beiersdorf's Eucerin in pharmacy channels, per a March 19, 2026 competitive analysis. Eucerin still grew +8.2% organically in Q1 2026, holding ground so far.

Is it safe to invest in or join Beiersdorf right now?

Beiersdorf's stock fell about 44% over 24 months and 20% year-to-date as of March 31, 2026, with short interest rising to 9.8% of free float. Headcount was stable at 22,399 (Dec 31, 2025) with no reported mass layoffs, and a €750 million buyback was announced.

Consumer brands · subsidiary of Maxingvest GmbH & Co. KGaA · Germany

Beiersdorf AG

beiersdorf.com ↗

German maker of Nivea, Eucerin and tesa tape, 144 years old and family controlled.

Hard to displace

Assessed 23 July 2026 · Evidence as of 23 July 2026

Strong structural protection; the business model survives ai pressure.

On the recordSince 23 July 2026 · Checkable from August 5, 2026 · Every call on the record Checkpoint: H1 2026 results, checkpoint on Nivea rebalancing progress

The call

Nivea is shrinking while Eucerin holds its ground against L'Oréal, with family ownership buying time for the turnaround to prove itself.

Beiersdorf makes and sells skincare and adhesive products, with NIVEA as its flagship brand sold worldwide and Eucerin in pharmacies. The company is hard to knock out because of its 144-year history, trusted brand names, and deep relationships with stores and pharmacies across 170 countries, but L'Oréal's competing skincare brands like CeraVe are winning customers in pharmacies where Eucerin has traditionally been strong. The critical question is whether NIVEA can stop shrinking (it dropped 7% in early 2026 after barely growing in 2025); if the brand stabilizes and starts growing again by the middle of 2026, the company stays solid, but if the decline gets worse, NIVEA could become just a cash machine that slowly loses ground, which would hurt the stock and the company's ability to invest in new products.

Why

AI pressure: L'Oréal's Perso AI skin diagnostic tool and Skin Genius app. AI skin scanners steer shoppers to CeraVe and La Roche-Posay instead of Nivea or Eucerin at the point of purchase. Could AI do the core job? Unlikely.

Bigger players: L'Oréal (CeraVe, La Roche-Posay, Vichy dermocosmetics). L'Oréal's dermo brands are grabbing pharmacy shelf space while Nivea sales fell 7.0% in Q1 2026. Could a giant copy it? No, they are blocked.

What protects it. Maxingvest family holds 53.5% and funds a slow Nivea rebalancing without needing to please quarterly traders.

What would change this call

Beiersdorf H1 2026 results on August 5, 2026 show NIVEA organic growth still negative. Would indicate NIVEA's decline is deepening rather than stabilizing as management promised.
Eucerin/Derma organic growth in 2026 quarterly reports falls below mid-single digits. Would confirm L'Oreal's dermocosmetics brands are winning share from Eucerin.
Maxingvest/Herz family reduces its 53-58% Beiersdorf stake or announces sale intent. Would remove the family-control ownership stability underpinning the company's moat.

Key numbers

Nivea organic sales fell 7.0% in Q1 2026 (2026-04-21)
Eucerin/Derma grew 8.2% organically in Q1 2026 (2026-04-21)
Maxingvest family owns 53.5% of Beiersdorf shares (2026)

Named risks

NIVEA organic sales fell -7.0% in Q1 2026 after only +0.9% growth in 2025. Severity: high
La Prairie declined -10.7% in H1 2025 on China and travel-retail weakness. Severity: medium
Short interest rose to 9.8% of free float by March 2026, signaling bearish positioning. Severity: medium
L'Oréal's dermocosmetics brands actively contesting Eucerin's pharmacy channel share. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
L'Oréal	contesting	CeraVe, La Roche-Posay, Vichy pressuring Eucerin in pharmacy channels, per March 19, 2026 analysis
L'Oréal	losing to	L'Oréal beauty sales roughly $47.0 billion vs Beiersdorf Consumer €8.2 billion, FY2025
Indie and K-beauty DTC brands	gaining on	Flagged as emerging share-erosion threat in facial and sun care, March 2026 analysis

Questions people ask

Is Beiersdorf profitable in 2026?: Yes. Beiersdorf reported FY2025 EBIT excluding special factors of €1.4 billion, a 14.0% margin, on group sales of €9.9 billion, as of March 2, 2026. However Q1 2026 organic sales fell -4.6% and NIVEA declined -7.0%, pressuring near-term results.
Is NIVEA in trouble at Beiersdorf?: NIVEA's organic growth slowed to just +0.9% in 2025, then fell -7.0% in Q1 2026 (reported April 21, 2026), prompting a 'NIVEA rebalancing' strategy. Management has said meaningful improvement is expected later in 2026 and into 2027, not immediately.
Who owns Beiersdorf AG?: Beiersdorf is majority controlled by Maxingvest GmbH & Co. KGaA, the Herz family's holding company (formerly Tchibo Holding), which owns 53.50% per Beiersdorf's own investor relations page. Free float is 37.13%, with BlackRock holding roughly 2.96-3.05% as of October 23, 2025.
Could AI replace Beiersdorf's business?: Unlikely for its core products. Beiersdorf holds 140+ years of proprietary clinical skin data, a patented epigenetic 'Skin Age Clock' algorithm (patented since 2021), and 170+ market distribution. AI mainly threatens its consumer diagnostic apps, not its brand or manufacturing moat.
Who is Beiersdorf's biggest competitor?: L'Oréal, whose dermocosmetics brands CeraVe, La Roche-Posay, and Vichy are directly contesting Beiersdorf's Eucerin in pharmacy channels, per a March 19, 2026 competitive analysis. Eucerin still grew +8.2% organically in Q1 2026, holding ground so far.
Is it safe to invest in or join Beiersdorf right now?: Beiersdorf's stock fell about 44% over 24 months and 20% year-to-date as of March 31, 2026, with short interest rising to 9.8% of free float. Headcount was stable at 22,399 (Dec 31, 2025) with no reported mass layoffs, and a €750 million buyback was announced.

Timeline

2026-07-23Market cap approximately €17.2 billion, 52-week range €67.08-€113.10
2026-04-21Q1 2026 results: group organic sales -4.6%, NIVEA -7.0%, Derma +8.2%
2026-03-31€100 million Skin Care Innovation Fund launched
2026-03-31UBS upgrades Beiersdorf to neutral after 44% share price decline, PT €80
2026-03-02FY2025 results: €9.9B sales, +2.4% organic, 14.0% EBIT margin, €750M buyback announced
2025-12-31Group headcount reaches 22,399, up 0.6% year-on-year
2025-10-02NIVEA MEN and Real Madrid extend global partnership through 2030
2025-06-30La Prairie sales decline -10.7% in H1 2025 on China and travel-retail weakness
2021Skin Age Clock epigenetic algorithm (Epicelline) patented
2020-04-21NIVEA launches SKiN GUiDE AI-based web app

Revision history

23 July 2026

First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.

In the same band

Hermes International Compagnie Financiere Richemont Inditex (Zara)